enGene Therapeutics (ENGN) Consolidated Net Income (2023 - 2026)
enGene Therapeutics (ENGN) reported Consolidated Net Income of -$32.5 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$28.99 million a year earlier.
Powered by 
Analysis
enGene Therapeutics (ENGN) Consolidated Net Income (2023 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, enGene Therapeutics' Consolidated Net Income came in at -$130.36 million; for FY2025 (ended Oct 31, 2025), it came in at -$117.3 million.
- By fiscal year, Consolidated Net Income came in at -$55.14 million in FY2024, -$99.92 million in FY2023 and -$24.46 million in FY2022.
- Five-year quarterly Consolidated Net Income spans a low of -$82.5 million in fiscal Q4 2023 and a high of -$4.72 million in fiscal Q3 2023.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$30.23 million (Q2 2026), -$29.75 million (Q1 2026) and -$37.88 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.25 Bn |
| 10 | enGene Therapeutics | 161.50 Mn | -832.97 Mn | - | 32.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 32.71 Mn |
| Apr 30, 2026 | 30.53 Mn |
| Jan 31, 2026 | 29.71 Mn |
| Oct 31, 2025 | 37.56 Mn |
| Jul 31, 2025 | 29.23 Mn |
| Apr 30, 2025 | 25.51 Mn |
| Jan 31, 2025 | 24.47 Mn |
| Oct 31, 2024 | 14.90 Mn |
| Jul 31, 2024 | 14.15 Mn |
| Apr 30, 2024 | 14.98 Mn |
| Jan 31, 2024 | 10.71 Mn |
| Oct 31, 2023 | -82.50 Mn |
| Jul 31, 2023 | -4.72 Mn |
| Apr 30, 2023 | -5.28 Mn |
| Jan 31, 2023 | -7.42 Mn |
API Access
enGene Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();